Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Amyloidosis × Vinorelbine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 139 Carcinoma, Non-Small-Cell Lung 93 Lung Neoplasms 48 Hodgkin Disease 20 Lymphoma 15 Recurrence 14 Neoplasm Metastasis 14 Neoplasms 12 Triple Negative Breast Neoplasms 11 Prostatic Neoplasms 10 Sarcoma 8 Lymphoma, Non-Hodgkin 8 Uterine Cervical Neoplasms 7 Rhabdomyosarcoma 7 Lymphoma, Large B-Cell, Diffuse 6 Adenocarcinoma of Lung 6 Mesothelioma, Malignant 5 Breast Neoplasms, Male 5 Small Cell Lung Carcinoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 NSCLC 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Multiple Myeloma 3 Mesothelioma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Lymphocytic, Chronic, B-Cell 3

Interventions

Dexamethasone 16 Melphalan 9 Calcium Dobesilate 8 Bortezomib 7 Cyclophosphamide 6 Lenalidomide 5 miridesap 3 pomalidomide 2 ixazomib 2 belantamab mafodotin 2 Thalidomide 2 Doxycycline 2 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2 venetoclax 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 daratumumab 1 carfilzomib 1 birtamimab 1 auricularum 1 Vinorelbine 1 Technetium Tc 99m Pyrophosphate 1 Technetium 1 Tacrolimus 1 Surveys and Questionnaires 1 Pharmaceutical Preparations 1 Lisaftoclax 1 Interleukin-2 1 Hyaluronoglucosaminidase 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02791373 2018-04-03

ViGeM

Insel Gruppe AG, University Hospital Bern

Phase 2 Completed

Amyloidosis, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡